Quest for Health Systems

Digital imaging technology and artificial intelligence are combining to remake the field of pathology by improving patient care while helping to address staffing challenges that face every healthcare institution. That was the message from our own Darren Wheeler MD, vice president for Pathology and Medical Services at Quest Diagnostics, who spoke in a recent webinar sponsored by the American College of Healthcare Executives. Click below to read the blog and watch the full webinar.

Every minute matters in sepsis care. We now have a test solution that brings faster results on the identification of the bacterial pathogens and resistance markers commonly associated with sepsis. This molecular test can deliver results in 1–2 hours from blood culture positivity to support clinicians’ discontinuation of empiric broad spectrum antimicrobial therapy days sooner, a practice associated with better patient outcomes. Reach out to your Quest representative or learn more here: https://lnkd.in/enrWdYnQ

Watch our recent webinar with the American College of Healthcare Executives and our own Darren Wheeler MD, where you'll: 🔍 Observe how the speed to diagnosis improves with digital pathology 📈 Understand how digital pathology can help increase staffing productivity 🏥 Learn how AI helps address the current workforce shortage of pathologists Click below to watch now.

If you’re headed to the American College of Healthcare Executives Atlanta Cluster next week, we invite you to join us to learn about the lab of the future on Monday night, 10.21 from 5:00-6:00 PM ET. Be sure to stop by to discover how healthcare executives are preparing their health systems for the lab of the future, with Quest expert Donna Young, MBA, BSMT, DLM (ASCP). We hope to see you there! #HealthcareExecutives

As AI advancements progress, digital pathology will continue to elevate cancer diagnosis, treatment, and maintenance for both patients and providers. That’s what Dr. Darren Wheeler, VP of Pathology and Medical Services at Quest Diagnostics, discusses in our latest episode of Diagnostic Dialogues. Listen to the episode below: https://lnkd.in/gKbsbf-A  

We hope you are planning to attend the American College of Healthcare Executives 2024 Atlanta Cluster. We invite you to join us at our educational session on Monday, 10.21 beginning at 5:00 PM ET featuring Quest expert Donna Young, MBA, BSMT, DLM (ASCP) This is a great opportunity to learn to: ➡️ Identify the core technological advances impacting the clinical laboratory today and into the future ➡️ Discover how healthcare executives are preparing their health systems for the lab of the future

The role pathologists play in the journey of cancer diagnosis, treatment, and care is vital. As more technological advancements, like digital pathology, are made available to pathologists, their impact will extend into developing stronger care strategies and better decision-making practices for both patients and providers. Get a deeper understanding of the changing landscape of pathology and how Quest Diagnostics is leading the way below: #digitalpathology

There is still time to join us tomorrow for our webinar, Digital Pathology and the AI Experience with the American College of Healthcare Executives where you'll: 🔍 Observe how the speed to diagnosis improves with digital pathology 📈 Understand how digital pathology can help increase staffing productivity 🏥 Learn how AI helps address the current workforce shortage of pathologists Our distinguished speaker is our own expert Darren Wheeler MD Wednesday, October 9, 2024 11:00 AM CT / 12:00 PM ET #HealthcareInnovation #Webinar #DigitalPathology

Advancing CMV treatment through genotypic resistance testing, offered by Quest Boost your transplant center’s success with the new cytomegalovirus (CMV) genotypic resistance testing, offered by Quest. This test is a differentiator for managing CMV infections, helping ensure better patient outcomes through tailored antiviral therapies. Interested in learning more?

Stay ahead of CMV with genotypic resistance testing at Quest. Managing refractory cytomegalovirus (CMV) infections in transplant patients just got easier. The new CMV genotypic resistance test, offered by Quest, accurately identifies resistance, helping you select the most appropriate antiviral medication. Minimize complications and enhance overall transplant success rates.